Skip to main content
SpringerLink
Log in

Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration

  • Letter to the Editor
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Roberts T, Sanghera S, Frew E. Adapting the CHEERS statement for reporting cost-benefit analysis. Pharmacoeconomics (in press).

  2. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—explanation and elaboration: a report of the ISPOR Health Economic Evaluations Publication Guidelines Task Force. Value Health. 2013;16(2) (in press).

  3. Hopewell S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, et al. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med. 2008;5(1):e20.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C, et al. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med. 2006;144(5):364–7.

    Article  PubMed  Google Scholar 

  5. McIntosh E, Clarke P, Frew EJ, Louviere JJ. Applied Methods of Cost-benefit Analysis in Health Care. 1 edition. Oxford; New York: Oxford University Press; 2010.

  6. Neumann PJ, Thorat T, Shi J, Saret CJ, Cohen JT. The changing face of the cost-utility literature, 1990–2012. Value Health J Int Soc Pharmacoecon Outcomes Res. 2015;18(2):271–7.

    Article  Google Scholar 

  7. Drummond MF, Sculpher MJ, Torrance G, O’Brien B, Stoddart G. Methods for the Economic Evaluation of Health Care Programmes. Third Edition. Oxford University Press; 2005.

Download references

Conflict of interest

Don Husereau is Chair of the CHEERS Task Force, and has served on the Board of Directors for the study funder (ISPOR) as well as received directed contracts for unrelated work from ISPOR and support for travel to a face-to-face meeting to discuss the contents of the report. All authors have completed the ICMJE uniform disclosure from at www.icmje.org/coi.disclosure.pdf and declare: FA and MD have also served as board members for the study funder; FA, AHB, CC, MD, DG, DH, EL, JM, and SP were provided support for travel to a face-to-face meeting to discuss the contents of the report; FA and MD have received payment from the study sponsor for serving as co-editors for Value in Health; no other relationships or activities that could appear to have influenced the submitted work have occurred. CC is the editor of this journal.

Author information

Authors and Affiliations

  1. Institute of Health Economics, Edmonton, AB, Canada

    Don Husereau

  2. Centre for Health Economics, University of York, York, UK

    Michael Drummond

  3. Warwick Medical School, University of Warwick, Coventry, UK

    Stavros Petrou

  4. Department of Health Systems Management, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel

    Dan Greenberg

  5. RTI Health Solutions, Research Triangle Park, NC, USA

    Josephine Mauskopf

  6. Health Economic Evaluation and Technology Assessment, Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina

    Federico Augustovski

  7. Health Economics and Health Technology Assessment, Institute of Health and Wellbeing, University of Glasgow, Glasgow, Scotland

    Andrew H. Briggs

  8. Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada

    David Moher

  9. BMJ, London, UK

    Elizabeth Loder

  10. PharmacoEconomics, Adis International, Auckland, New Zealand

    Chris Carswell

Authors
  1. Don Husereau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Drummond
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stavros Petrou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dan Greenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Josephine Mauskopf
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Federico Augustovski
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Andrew H. Briggs
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. David Moher
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Elizabeth Loder
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Chris Carswell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Don Husereau.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Husereau, D., Drummond, M., Petrou, S. et al. Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration. PharmacoEconomics 33, 535–536 (2015). https://doi.org/10.1007/s40273-015-0277-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40273-015-0277-8

Keywords

Search

Navigation